0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Non-opioid Topical Pain Relief - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Published Date: October 2024
|
Report Code: QYRE-Auto-19X14175
Home | Market Reports | Health| Pharmacy| Drugs & Medications
Global Non opioid Topical Pain Relief Market Research Report 2023
BUY CHAPTERS

Non-opioid Topical Pain Relief - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-19X14175
Report
October 2024
Pages:135
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Non-opioid Topical Pain Relief - Market Size

The global market for Non-opioid Topical Pain Relief was estimated to be worth US$ 854.9 million in 2023 and is forecast to a readjusted size of US$ 1204.9 million by 2030 with a CAGR of 4.2% during the forecast period 2024-2030

Non-opioid Topical Pain Relief - Market

Non-opioid Topical Pain Relief - Market

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Non-opioid Topical Pain Relief, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Non-opioid Topical Pain Relief by region & country, by Type, and by Application.
The Non-opioid Topical Pain Relief market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Non-opioid Topical Pain Relief.
Market Segmentation

Scope of Non-opioid Topical Pain Relief - Market Report

Report Metric Details
Report Name Non-opioid Topical Pain Relief - Market
Forecasted market size in 2030 US$ 1204.9 million
CAGR 4.2%
Forecasted years 2024 - 2030
Segment by Type:
  • Prescription Pain Relief
  • Over-The-Counter Pain Relief
Segment by Application
  • Pharmacy
  • Clinic
  • Hospital
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Johnson and Johnson, GlaxoSmithKline, Pfizer, Hisamitsu, Mylan, Reckitt Benckiser Group, Sanofi, Teva Pharmaceutical, Sun Pharmaceutical Industries, Lingrui Pharmaceutical, Tibet Cheezheng Tibetan Medicine, China Resources Sanjiu Medical & Pharmaceutical, Topical BioMedics, AdvaCare Pharma, Abacus Health Products
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 2: Detailed analysis of Non-opioid Topical Pain Relief manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 5: Sales, revenue of Non-opioid Topical Pain Relief in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 6: Sales, revenue of Non-opioid Topical Pain Relief in country level. It provides sigmate data by Type, and by Application for each country/region.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Conclusion.

FAQ for this report

What is the Non-opioid Topical Pain Relief - Market size in 2030?

Ans: The Non-opioid Topical Pain Relief - Market size in 2030 will be US$ 1204.9 million.

Who are the main players in the Non-opioid Topical Pain Relief - Market report?

Ans: The main players in the Non-opioid Topical Pain Relief - Market are Johnson and Johnson, GlaxoSmithKline, Pfizer, Hisamitsu, Mylan, Reckitt Benckiser Group, Sanofi, Teva Pharmaceutical, Sun Pharmaceutical Industries, Lingrui Pharmaceutical, Tibet Cheezheng Tibetan Medicine, China Resources Sanjiu Medical & Pharmaceutical, Topical BioMedics, AdvaCare Pharma, Abacus Health Products

What are the Application segmentation covered in the Non-opioid Topical Pain Relief - Market report?

Ans: The Applications covered in the Non-opioid Topical Pain Relief - Market report are Pharmacy, Clinic, Hospital, Others

What are the Type segmentation covered in the Non-opioid Topical Pain Relief - Market report?

Ans: The Types covered in the Non-opioid Topical Pain Relief - Market report are Prescription Pain Relief, Over-The-Counter Pain Relief

1 Market Overview
1.1 Non-opioid Topical Pain Relief Product Introduction
1.2 Global Non-opioid Topical Pain Relief Market Size Forecast
1.2.1 Global Non-opioid Topical Pain Relief Sales Value (2019-2030)
1.2.2 Global Non-opioid Topical Pain Relief Sales Volume (2019-2030)
1.2.3 Global Non-opioid Topical Pain Relief Sales Price (2019-2030)
1.3 Non-opioid Topical Pain Relief Market Trends & Drivers
1.3.1 Non-opioid Topical Pain Relief Industry Trends
1.3.2 Non-opioid Topical Pain Relief Market Drivers & Opportunity
1.3.3 Non-opioid Topical Pain Relief Market Challenges
1.3.4 Non-opioid Topical Pain Relief Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Non-opioid Topical Pain Relief Players Revenue Ranking (2023)
2.2 Global Non-opioid Topical Pain Relief Revenue by Company (2019-2024)
2.3 Global Non-opioid Topical Pain Relief Players Sales Volume Ranking (2023)
2.4 Global Non-opioid Topical Pain Relief Sales Volume by Company Players (2019-2024)
2.5 Global Non-opioid Topical Pain Relief Average Price by Company (2019-2024)
2.6 Key Manufacturers Non-opioid Topical Pain Relief Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Non-opioid Topical Pain Relief Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Non-opioid Topical Pain Relief
2.9 Non-opioid Topical Pain Relief Market Competitive Analysis
2.9.1 Non-opioid Topical Pain Relief Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Non-opioid Topical Pain Relief Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Non-opioid Topical Pain Relief as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Prescription Pain Relief
3.1.2 Over-The-Counter Pain Relief
3.2 Global Non-opioid Topical Pain Relief Sales Value by Type
3.2.1 Global Non-opioid Topical Pain Relief Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Non-opioid Topical Pain Relief Sales Value, by Type (2019-2030)
3.2.3 Global Non-opioid Topical Pain Relief Sales Value, by Type (%) (2019-2030)
3.3 Global Non-opioid Topical Pain Relief Sales Volume by Type
3.3.1 Global Non-opioid Topical Pain Relief Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Non-opioid Topical Pain Relief Sales Volume, by Type (2019-2030)
3.3.3 Global Non-opioid Topical Pain Relief Sales Volume, by Type (%) (2019-2030)
3.4 Global Non-opioid Topical Pain Relief Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Pharmacy
4.1.2 Clinic
4.1.3 Hospital
4.1.4 Others
4.2 Global Non-opioid Topical Pain Relief Sales Value by Application
4.2.1 Global Non-opioid Topical Pain Relief Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Non-opioid Topical Pain Relief Sales Value, by Application (2019-2030)
4.2.3 Global Non-opioid Topical Pain Relief Sales Value, by Application (%) (2019-2030)
4.3 Global Non-opioid Topical Pain Relief Sales Volume by Application
4.3.1 Global Non-opioid Topical Pain Relief Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Non-opioid Topical Pain Relief Sales Volume, by Application (2019-2030)
4.3.3 Global Non-opioid Topical Pain Relief Sales Volume, by Application (%) (2019-2030)
4.4 Global Non-opioid Topical Pain Relief Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Non-opioid Topical Pain Relief Sales Value by Region
5.1.1 Global Non-opioid Topical Pain Relief Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Non-opioid Topical Pain Relief Sales Value by Region (2019-2024)
5.1.3 Global Non-opioid Topical Pain Relief Sales Value by Region (2025-2030)
5.1.4 Global Non-opioid Topical Pain Relief Sales Value by Region (%), (2019-2030)
5.2 Global Non-opioid Topical Pain Relief Sales Volume by Region
5.2.1 Global Non-opioid Topical Pain Relief Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Non-opioid Topical Pain Relief Sales Volume by Region (2019-2024)
5.2.3 Global Non-opioid Topical Pain Relief Sales Volume by Region (2025-2030)
5.2.4 Global Non-opioid Topical Pain Relief Sales Volume by Region (%), (2019-2030)
5.3 Global Non-opioid Topical Pain Relief Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Non-opioid Topical Pain Relief Sales Value, 2019-2030
5.4.2 North America Non-opioid Topical Pain Relief Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Non-opioid Topical Pain Relief Sales Value, 2019-2030
5.5.2 Europe Non-opioid Topical Pain Relief Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Non-opioid Topical Pain Relief Sales Value, 2019-2030
5.6.2 Asia Pacific Non-opioid Topical Pain Relief Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Non-opioid Topical Pain Relief Sales Value, 2019-2030
5.7.2 South America Non-opioid Topical Pain Relief Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Non-opioid Topical Pain Relief Sales Value, 2019-2030
5.8.2 Middle East & Africa Non-opioid Topical Pain Relief Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Non-opioid Topical Pain Relief Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Non-opioid Topical Pain Relief Sales Value
6.2.1 Key Countries/Regions Non-opioid Topical Pain Relief Sales Value, 2019-2030
6.2.2 Key Countries/Regions Non-opioid Topical Pain Relief Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Non-opioid Topical Pain Relief Sales Value, 2019-2030
6.3.2 United States Non-opioid Topical Pain Relief Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Non-opioid Topical Pain Relief Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Non-opioid Topical Pain Relief Sales Value, 2019-2030
6.4.2 Europe Non-opioid Topical Pain Relief Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Non-opioid Topical Pain Relief Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Non-opioid Topical Pain Relief Sales Value, 2019-2030
6.5.2 China Non-opioid Topical Pain Relief Sales Value by Type (%), 2023 VS 2030
6.5.3 China Non-opioid Topical Pain Relief Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Non-opioid Topical Pain Relief Sales Value, 2019-2030
6.6.2 Japan Non-opioid Topical Pain Relief Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Non-opioid Topical Pain Relief Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Non-opioid Topical Pain Relief Sales Value, 2019-2030
6.7.2 South Korea Non-opioid Topical Pain Relief Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Non-opioid Topical Pain Relief Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Non-opioid Topical Pain Relief Sales Value, 2019-2030
6.8.2 Southeast Asia Non-opioid Topical Pain Relief Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Non-opioid Topical Pain Relief Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Non-opioid Topical Pain Relief Sales Value, 2019-2030
6.9.2 India Non-opioid Topical Pain Relief Sales Value by Type (%), 2023 VS 2030
6.9.3 India Non-opioid Topical Pain Relief Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Johnson and Johnson
7.1.1 Johnson and Johnson Company Information
7.1.2 Johnson and Johnson Introduction and Business Overview
7.1.3 Johnson and Johnson Non-opioid Topical Pain Relief Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Johnson and Johnson Non-opioid Topical Pain Relief Product Offerings
7.1.5 Johnson and Johnson Recent Development
7.2 GlaxoSmithKline
7.2.1 GlaxoSmithKline Company Information
7.2.2 GlaxoSmithKline Introduction and Business Overview
7.2.3 GlaxoSmithKline Non-opioid Topical Pain Relief Sales, Revenue and Gross Margin (2019-2024)
7.2.4 GlaxoSmithKline Non-opioid Topical Pain Relief Product Offerings
7.2.5 GlaxoSmithKline Recent Development
7.3 Pfizer
7.3.1 Pfizer Company Information
7.3.2 Pfizer Introduction and Business Overview
7.3.3 Pfizer Non-opioid Topical Pain Relief Sales, Revenue and Gross Margin (2019-2024)
7.3.4 Pfizer Non-opioid Topical Pain Relief Product Offerings
7.3.5 Pfizer Recent Development
7.4 Hisamitsu
7.4.1 Hisamitsu Company Information
7.4.2 Hisamitsu Introduction and Business Overview
7.4.3 Hisamitsu Non-opioid Topical Pain Relief Sales, Revenue and Gross Margin (2019-2024)
7.4.4 Hisamitsu Non-opioid Topical Pain Relief Product Offerings
7.4.5 Hisamitsu Recent Development
7.5 Mylan
7.5.1 Mylan Company Information
7.5.2 Mylan Introduction and Business Overview
7.5.3 Mylan Non-opioid Topical Pain Relief Sales, Revenue and Gross Margin (2019-2024)
7.5.4 Mylan Non-opioid Topical Pain Relief Product Offerings
7.5.5 Mylan Recent Development
7.6 Reckitt Benckiser Group
7.6.1 Reckitt Benckiser Group Company Information
7.6.2 Reckitt Benckiser Group Introduction and Business Overview
7.6.3 Reckitt Benckiser Group Non-opioid Topical Pain Relief Sales, Revenue and Gross Margin (2019-2024)
7.6.4 Reckitt Benckiser Group Non-opioid Topical Pain Relief Product Offerings
7.6.5 Reckitt Benckiser Group Recent Development
7.7 Sanofi
7.7.1 Sanofi Company Information
7.7.2 Sanofi Introduction and Business Overview
7.7.3 Sanofi Non-opioid Topical Pain Relief Sales, Revenue and Gross Margin (2019-2024)
7.7.4 Sanofi Non-opioid Topical Pain Relief Product Offerings
7.7.5 Sanofi Recent Development
7.8 Teva Pharmaceutical
7.8.1 Teva Pharmaceutical Company Information
7.8.2 Teva Pharmaceutical Introduction and Business Overview
7.8.3 Teva Pharmaceutical Non-opioid Topical Pain Relief Sales, Revenue and Gross Margin (2019-2024)
7.8.4 Teva Pharmaceutical Non-opioid Topical Pain Relief Product Offerings
7.8.5 Teva Pharmaceutical Recent Development
7.9 Sun Pharmaceutical Industries
7.9.1 Sun Pharmaceutical Industries Company Information
7.9.2 Sun Pharmaceutical Industries Introduction and Business Overview
7.9.3 Sun Pharmaceutical Industries Non-opioid Topical Pain Relief Sales, Revenue and Gross Margin (2019-2024)
7.9.4 Sun Pharmaceutical Industries Non-opioid Topical Pain Relief Product Offerings
7.9.5 Sun Pharmaceutical Industries Recent Development
7.10 Lingrui Pharmaceutical
7.10.1 Lingrui Pharmaceutical Company Information
7.10.2 Lingrui Pharmaceutical Introduction and Business Overview
7.10.3 Lingrui Pharmaceutical Non-opioid Topical Pain Relief Sales, Revenue and Gross Margin (2019-2024)
7.10.4 Lingrui Pharmaceutical Non-opioid Topical Pain Relief Product Offerings
7.10.5 Lingrui Pharmaceutical Recent Development
7.11 Tibet Cheezheng Tibetan Medicine
7.11.1 Tibet Cheezheng Tibetan Medicine Company Information
7.11.2 Tibet Cheezheng Tibetan Medicine Introduction and Business Overview
7.11.3 Tibet Cheezheng Tibetan Medicine Non-opioid Topical Pain Relief Sales, Revenue and Gross Margin (2019-2024)
7.11.4 Tibet Cheezheng Tibetan Medicine Non-opioid Topical Pain Relief Product Offerings
7.11.5 Tibet Cheezheng Tibetan Medicine Recent Development
7.12 China Resources Sanjiu Medical & Pharmaceutical
7.12.1 China Resources Sanjiu Medical & Pharmaceutical Company Information
7.12.2 China Resources Sanjiu Medical & Pharmaceutical Introduction and Business Overview
7.12.3 China Resources Sanjiu Medical & Pharmaceutical Non-opioid Topical Pain Relief Sales, Revenue and Gross Margin (2019-2024)
7.12.4 China Resources Sanjiu Medical & Pharmaceutical Non-opioid Topical Pain Relief Product Offerings
7.12.5 China Resources Sanjiu Medical & Pharmaceutical Recent Development
7.13 Topical BioMedics
7.13.1 Topical BioMedics Company Information
7.13.2 Topical BioMedics Introduction and Business Overview
7.13.3 Topical BioMedics Non-opioid Topical Pain Relief Sales, Revenue and Gross Margin (2019-2024)
7.13.4 Topical BioMedics Non-opioid Topical Pain Relief Product Offerings
7.13.5 Topical BioMedics Recent Development
7.14 AdvaCare Pharma
7.14.1 AdvaCare Pharma Company Information
7.14.2 AdvaCare Pharma Introduction and Business Overview
7.14.3 AdvaCare Pharma Non-opioid Topical Pain Relief Sales, Revenue and Gross Margin (2019-2024)
7.14.4 AdvaCare Pharma Non-opioid Topical Pain Relief Product Offerings
7.14.5 AdvaCare Pharma Recent Development
7.15 Abacus Health Products
7.15.1 Abacus Health Products Company Information
7.15.2 Abacus Health Products Introduction and Business Overview
7.15.3 Abacus Health Products Non-opioid Topical Pain Relief Sales, Revenue and Gross Margin (2019-2024)
7.15.4 Abacus Health Products Non-opioid Topical Pain Relief Product Offerings
7.15.5 Abacus Health Products Recent Development
8 Industry Chain Analysis
8.1 Non-opioid Topical Pain Relief Industrial Chain
8.2 Non-opioid Topical Pain Relief Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Non-opioid Topical Pain Relief Sales Model
8.5.2 Sales Channel
8.5.3 Non-opioid Topical Pain Relief Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
    Table 1. Non-opioid Topical Pain Relief Market Trends
    Table 2. Non-opioid Topical Pain Relief Market Drivers & Opportunity
    Table 3. Non-opioid Topical Pain Relief Market Challenges
    Table 4. Non-opioid Topical Pain Relief Market Restraints
    Table 5. Global Non-opioid Topical Pain Relief Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Non-opioid Topical Pain Relief Revenue Market Share by Company (2019-2024)
    Table 7. Global Non-opioid Topical Pain Relief Sales Volume by Company (2019-2024) & (K Units)
    Table 8. Global Non-opioid Topical Pain Relief Sales Volume Market Share by Company (2019-2024)
    Table 9. Global Market Non-opioid Topical Pain Relief Price by Company (2019-2024) & (US$/Unit)
    Table 10. Key Manufacturers Non-opioid Topical Pain Relief Manufacturing Base Distribution and Headquarters
    Table 11. Key Manufacturers Non-opioid Topical Pain Relief Product Type
    Table 12. Key Manufacturers Time to Begin Mass Production of Non-opioid Topical Pain Relief
    Table 13. Global Non-opioid Topical Pain Relief Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Non-opioid Topical Pain Relief as of 2023)
    Table 15. Mergers & Acquisitions, Expansion Plans
    Table 16. Global Non-opioid Topical Pain Relief Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 17. Global Non-opioid Topical Pain Relief Sales Value by Type (2019-2024) & (US$ Million)
    Table 18. Global Non-opioid Topical Pain Relief Sales Value by Type (2025-2030) & (US$ Million)
    Table 19. Global Non-opioid Topical Pain Relief Sales Market Share in Value by Type (2019-2024) & (%)
    Table 20. Global Non-opioid Topical Pain Relief Sales Market Share in Value by Type (2025-2030) & (%)
    Table 21. Global Non-opioid Topical Pain Relief Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)
    Table 22. Global Non-opioid Topical Pain Relief Sales Volume by Type (2019-2024) & (K Units)
    Table 23. Global Non-opioid Topical Pain Relief Sales Volume by Type (2025-2030) & (K Units)
    Table 24. Global Non-opioid Topical Pain Relief Sales Market Share in Volume by Type (2019-2024) & (%)
    Table 25. Global Non-opioid Topical Pain Relief Sales Market Share in Volume by Type (2025-2030) & (%)
    Table 26. Global Non-opioid Topical Pain Relief Price by Type (2019-2024) & (US$/Unit)
    Table 27. Global Non-opioid Topical Pain Relief Price by Type (2025-2030) & (US$/Unit)
    Table 28. Global Non-opioid Topical Pain Relief Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 29. Global Non-opioid Topical Pain Relief Sales Value by Application (2019-2024) & (US$ Million)
    Table 30. Global Non-opioid Topical Pain Relief Sales Value by Application (2025-2030) & (US$ Million)
    Table 31. Global Non-opioid Topical Pain Relief Sales Market Share in Value by Application (2019-2024) & (%)
    Table 32. Global Non-opioid Topical Pain Relief Sales Market Share in Value by Application (2025-2030) & (%)
    Table 33. Global Non-opioid Topical Pain Relief Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)
    Table 34. Global Non-opioid Topical Pain Relief Sales Volume by Application (2019-2024) & (K Units)
    Table 35. Global Non-opioid Topical Pain Relief Sales Volume by Application (2025-2030) & (K Units)
    Table 36. Global Non-opioid Topical Pain Relief Sales Market Share in Volume by Application (2019-2024) & (%)
    Table 37. Global Non-opioid Topical Pain Relief Sales Market Share in Volume by Application (2025-2030) & (%)
    Table 38. Global Non-opioid Topical Pain Relief Price by Application (2019-2024) & (US$/Unit)
    Table 39. Global Non-opioid Topical Pain Relief Price by Application (2025-2030) & (US$/Unit)
    Table 40. Global Non-opioid Topical Pain Relief Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 41. Global Non-opioid Topical Pain Relief Sales Value by Region (2019-2024) & (US$ Million)
    Table 42. Global Non-opioid Topical Pain Relief Sales Value by Region (2025-2030) & (US$ Million)
    Table 43. Global Non-opioid Topical Pain Relief Sales Value by Region (2019-2024) & (%)
    Table 44. Global Non-opioid Topical Pain Relief Sales Value by Region (2025-2030) & (%)
    Table 45. Global Non-opioid Topical Pain Relief Sales Volume by Region (K Units): 2019 VS 2023 VS 2030
    Table 46. Global Non-opioid Topical Pain Relief Sales Volume by Region (2019-2024) & (K Units)
    Table 47. Global Non-opioid Topical Pain Relief Sales Volume by Region (2025-2030) & (K Units)
    Table 48. Global Non-opioid Topical Pain Relief Sales Volume by Region (2019-2024) & (%)
    Table 49. Global Non-opioid Topical Pain Relief Sales Volume by Region (2025-2030) & (%)
    Table 50. Global Non-opioid Topical Pain Relief Average Price by Region (2019-2024) & (US$/Unit)
    Table 51. Global Non-opioid Topical Pain Relief Average Price by Region (2025-2030) & (US$/Unit)
    Table 52. Key Countries/Regions Non-opioid Topical Pain Relief Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 53. Key Countries/Regions Non-opioid Topical Pain Relief Sales Value, (2019-2024) & (US$ Million)
    Table 54. Key Countries/Regions Non-opioid Topical Pain Relief Sales Value, (2025-2030) & (US$ Million)
    Table 55. Key Countries/Regions Non-opioid Topical Pain Relief Sales Volume, (2019-2024) & (K Units)
    Table 56. Key Countries/Regions Non-opioid Topical Pain Relief Sales Volume, (2025-2030) & (K Units)
    Table 57. Johnson and Johnson Company Information
    Table 58. Johnson and Johnson Introduction and Business Overview
    Table 59. Johnson and Johnson Non-opioid Topical Pain Relief Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 60. Johnson and Johnson Non-opioid Topical Pain Relief Product Offerings
    Table 61. Johnson and Johnson Recent Development
    Table 62. GlaxoSmithKline Company Information
    Table 63. GlaxoSmithKline Introduction and Business Overview
    Table 64. GlaxoSmithKline Non-opioid Topical Pain Relief Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 65. GlaxoSmithKline Non-opioid Topical Pain Relief Product Offerings
    Table 66. GlaxoSmithKline Recent Development
    Table 67. Pfizer Company Information
    Table 68. Pfizer Introduction and Business Overview
    Table 69. Pfizer Non-opioid Topical Pain Relief Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 70. Pfizer Non-opioid Topical Pain Relief Product Offerings
    Table 71. Pfizer Recent Development
    Table 72. Hisamitsu Company Information
    Table 73. Hisamitsu Introduction and Business Overview
    Table 74. Hisamitsu Non-opioid Topical Pain Relief Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 75. Hisamitsu Non-opioid Topical Pain Relief Product Offerings
    Table 76. Hisamitsu Recent Development
    Table 77. Mylan Company Information
    Table 78. Mylan Introduction and Business Overview
    Table 79. Mylan Non-opioid Topical Pain Relief Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 80. Mylan Non-opioid Topical Pain Relief Product Offerings
    Table 81. Mylan Recent Development
    Table 82. Reckitt Benckiser Group Company Information
    Table 83. Reckitt Benckiser Group Introduction and Business Overview
    Table 84. Reckitt Benckiser Group Non-opioid Topical Pain Relief Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 85. Reckitt Benckiser Group Non-opioid Topical Pain Relief Product Offerings
    Table 86. Reckitt Benckiser Group Recent Development
    Table 87. Sanofi Company Information
    Table 88. Sanofi Introduction and Business Overview
    Table 89. Sanofi Non-opioid Topical Pain Relief Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 90. Sanofi Non-opioid Topical Pain Relief Product Offerings
    Table 91. Sanofi Recent Development
    Table 92. Teva Pharmaceutical Company Information
    Table 93. Teva Pharmaceutical Introduction and Business Overview
    Table 94. Teva Pharmaceutical Non-opioid Topical Pain Relief Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 95. Teva Pharmaceutical Non-opioid Topical Pain Relief Product Offerings
    Table 96. Teva Pharmaceutical Recent Development
    Table 97. Sun Pharmaceutical Industries Company Information
    Table 98. Sun Pharmaceutical Industries Introduction and Business Overview
    Table 99. Sun Pharmaceutical Industries Non-opioid Topical Pain Relief Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 100. Sun Pharmaceutical Industries Non-opioid Topical Pain Relief Product Offerings
    Table 101. Sun Pharmaceutical Industries Recent Development
    Table 102. Lingrui Pharmaceutical Company Information
    Table 103. Lingrui Pharmaceutical Introduction and Business Overview
    Table 104. Lingrui Pharmaceutical Non-opioid Topical Pain Relief Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 105. Lingrui Pharmaceutical Non-opioid Topical Pain Relief Product Offerings
    Table 106. Lingrui Pharmaceutical Recent Development
    Table 107. Tibet Cheezheng Tibetan Medicine Company Information
    Table 108. Tibet Cheezheng Tibetan Medicine Introduction and Business Overview
    Table 109. Tibet Cheezheng Tibetan Medicine Non-opioid Topical Pain Relief Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 110. Tibet Cheezheng Tibetan Medicine Non-opioid Topical Pain Relief Product Offerings
    Table 111. Tibet Cheezheng Tibetan Medicine Recent Development
    Table 112. China Resources Sanjiu Medical & Pharmaceutical Company Information
    Table 113. China Resources Sanjiu Medical & Pharmaceutical Introduction and Business Overview
    Table 114. China Resources Sanjiu Medical & Pharmaceutical Non-opioid Topical Pain Relief Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 115. China Resources Sanjiu Medical & Pharmaceutical Non-opioid Topical Pain Relief Product Offerings
    Table 116. China Resources Sanjiu Medical & Pharmaceutical Recent Development
    Table 117. Topical BioMedics Company Information
    Table 118. Topical BioMedics Introduction and Business Overview
    Table 119. Topical BioMedics Non-opioid Topical Pain Relief Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 120. Topical BioMedics Non-opioid Topical Pain Relief Product Offerings
    Table 121. Topical BioMedics Recent Development
    Table 122. AdvaCare Pharma Company Information
    Table 123. AdvaCare Pharma Introduction and Business Overview
    Table 124. AdvaCare Pharma Non-opioid Topical Pain Relief Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 125. AdvaCare Pharma Non-opioid Topical Pain Relief Product Offerings
    Table 126. AdvaCare Pharma Recent Development
    Table 127. Abacus Health Products Company Information
    Table 128. Abacus Health Products Introduction and Business Overview
    Table 129. Abacus Health Products Non-opioid Topical Pain Relief Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 130. Abacus Health Products Non-opioid Topical Pain Relief Product Offerings
    Table 131. Abacus Health Products Recent Development
    Table 132. Key Raw Materials Lists
    Table 133. Raw Materials Key Suppliers Lists
    Table 134. Non-opioid Topical Pain Relief Downstream Customers
    Table 135. Non-opioid Topical Pain Relief Distributors List
    Table 136. Research Programs/Design for This Report
    Table 137. Key Data Information from Secondary Sources
    Table 138. Key Data Information from Primary Sources
List of Figures
    Figure 1. Non-opioid Topical Pain Relief Product Picture
    Figure 2. Global Non-opioid Topical Pain Relief Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Non-opioid Topical Pain Relief Sales Value (2019-2030) & (US$ Million)
    Figure 4. Global Non-opioid Topical Pain Relief Sales Volume (2019-2030) & (K Units)
    Figure 5. Global Non-opioid Topical Pain Relief Sales Price (2019-2030) & (US$/Unit)
    Figure 6. Non-opioid Topical Pain Relief Report Years Considered
    Figure 7. Global Non-opioid Topical Pain Relief Players Revenue Ranking (2023) & (US$ Million)
    Figure 8. Global Non-opioid Topical Pain Relief Players Sales Volume Ranking (2023) & (K Units)
    Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Non-opioid Topical Pain Relief Revenue in 2023
    Figure 10. Non-opioid Topical Pain Relief Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 11. Prescription Pain Relief Picture
    Figure 12. Over-The-Counter Pain Relief Picture
    Figure 13. Global Non-opioid Topical Pain Relief Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 14. Global Non-opioid Topical Pain Relief Sales Value Market Share by Type, 2023 & 2030
    Figure 15. Global Non-opioid Topical Pain Relief Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)
    Figure 16. Global Non-opioid Topical Pain Relief Sales Volume Market Share by Type, 2023 & 2030
    Figure 17. Global Non-opioid Topical Pain Relief Price by Type (2019-2030) & (US$/Unit)
    Figure 18. Product Picture of Pharmacy
    Figure 19. Product Picture of Clinic
    Figure 20. Product Picture of Hospital
    Figure 21. Product Picture of Others
    Figure 22. Global Non-opioid Topical Pain Relief Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 23. Global Non-opioid Topical Pain Relief Sales Value Market Share by Application, 2023 & 2030
    Figure 24. Global Non-opioid Topical Pain Relief Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)
    Figure 25. Global Non-opioid Topical Pain Relief Sales Volume Market Share by Application, 2023 & 2030
    Figure 26. Global Non-opioid Topical Pain Relief Price by Application (2019-2030) & (US$/Unit)
    Figure 27. North America Non-opioid Topical Pain Relief Sales Value (2019-2030) & (US$ Million)
    Figure 28. North America Non-opioid Topical Pain Relief Sales Value by Country (%), 2023 VS 2030
    Figure 29. Europe Non-opioid Topical Pain Relief Sales Value (2019-2030) & (US$ Million)
    Figure 30. Europe Non-opioid Topical Pain Relief Sales Value by Country (%), 2023 VS 2030
    Figure 31. Asia Pacific Non-opioid Topical Pain Relief Sales Value (2019-2030) & (US$ Million)
    Figure 32. Asia Pacific Non-opioid Topical Pain Relief Sales Value by Country (%), 2023 VS 2030
    Figure 33. South America Non-opioid Topical Pain Relief Sales Value (2019-2030) & (US$ Million)
    Figure 34. South America Non-opioid Topical Pain Relief Sales Value by Country (%), 2023 VS 2030
    Figure 35. Middle East & Africa Non-opioid Topical Pain Relief Sales Value (2019-2030) & (US$ Million)
    Figure 36. Middle East & Africa Non-opioid Topical Pain Relief Sales Value by Country (%), 2023 VS 2030
    Figure 37. Key Countries/Regions Non-opioid Topical Pain Relief Sales Value (%), (2019-2030)
    Figure 38. Key Countries/Regions Non-opioid Topical Pain Relief Sales Volume (%), (2019-2030)
    Figure 39. United States Non-opioid Topical Pain Relief Sales Value, (2019-2030) & (US$ Million)
    Figure 40. United States Non-opioid Topical Pain Relief Sales Value by Type (%), 2023 VS 2030
    Figure 41. United States Non-opioid Topical Pain Relief Sales Value by Application (%), 2023 VS 2030
    Figure 42. Europe Non-opioid Topical Pain Relief Sales Value, (2019-2030) & (US$ Million)
    Figure 43. Europe Non-opioid Topical Pain Relief Sales Value by Type (%), 2023 VS 2030
    Figure 44. Europe Non-opioid Topical Pain Relief Sales Value by Application (%), 2023 VS 2030
    Figure 45. China Non-opioid Topical Pain Relief Sales Value, (2019-2030) & (US$ Million)
    Figure 46. China Non-opioid Topical Pain Relief Sales Value by Type (%), 2023 VS 2030
    Figure 47. China Non-opioid Topical Pain Relief Sales Value by Application (%), 2023 VS 2030
    Figure 48. Japan Non-opioid Topical Pain Relief Sales Value, (2019-2030) & (US$ Million)
    Figure 49. Japan Non-opioid Topical Pain Relief Sales Value by Type (%), 2023 VS 2030
    Figure 50. Japan Non-opioid Topical Pain Relief Sales Value by Application (%), 2023 VS 2030
    Figure 51. South Korea Non-opioid Topical Pain Relief Sales Value, (2019-2030) & (US$ Million)
    Figure 52. South Korea Non-opioid Topical Pain Relief Sales Value by Type (%), 2023 VS 2030
    Figure 53. South Korea Non-opioid Topical Pain Relief Sales Value by Application (%), 2023 VS 2030
    Figure 54. Southeast Asia Non-opioid Topical Pain Relief Sales Value, (2019-2030) & (US$ Million)
    Figure 55. Southeast Asia Non-opioid Topical Pain Relief Sales Value by Type (%), 2023 VS 2030
    Figure 56. Southeast Asia Non-opioid Topical Pain Relief Sales Value by Application (%), 2023 VS 2030
    Figure 57. India Non-opioid Topical Pain Relief Sales Value, (2019-2030) & (US$ Million)
    Figure 58. India Non-opioid Topical Pain Relief Sales Value by Type (%), 2023 VS 2030
    Figure 59. India Non-opioid Topical Pain Relief Sales Value by Application (%), 2023 VS 2030
    Figure 60. Non-opioid Topical Pain Relief Industrial Chain
    Figure 61. Non-opioid Topical Pain Relief Manufacturing Cost Structure
    Figure 62. Channels of Distribution (Direct Sales, and Distribution)
    Figure 63. Bottom-up and Top-down Approaches for This Report
    Figure 64. Data Triangulation
    Figure 65. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3950

This license allows only one user to access the PDF.
Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Nano Dimension

SIMILAR REPORTS

RELATED REPORTS

Global Nuclear Radiation Therapeutic Drugs Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-37K14010
Wed May 14 00:00:00 UTC 2025

Add to Cart

Global Pharmaceutical Grade Trazodone Hydrochloride Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-1G14266
Wed May 14 00:00:00 UTC 2025

Add to Cart

Global Chemotherapy Cold Hat Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-35B14358
Wed May 14 00:00:00 UTC 2025

Add to Cart

Global Nasal Care Device Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-19G14399
Wed May 14 00:00:00 UTC 2025

Add to Cart

OSZAR »